Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, California, USA.
Clin J Am Soc Nephrol. 2010 Nov;5(11):2093-100. doi: 10.2215/CJN.03730410. Epub 2010 Aug 12.
Vascular calcification is common and severe in chronic kidney disease. Because the consequences of calcification may differ by vascular beds, we sought to test the hypothesis that patients who have diabetes with proteinuria and have significant renal artery calcification (RAC) have a higher risk for progression to ESRD.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using electron-beam computed tomography, RAC was computed as the sum of Agatston scores at each of the two renal ostia and renal arteries. Time-to-event analysis was conducted to compare the risk in individuals with or without significant RAC (total score >10).
Of 172 patients with type 2 diabetes and overt proteinuria studied (estimated GFR 56 ± 25 ml/min per 1.73 m(2)), significant RAC was present in 31%. In 33 ± 21 months, 41 progressed to ESRD and 65 reached a composite outcome (ESRD or death). Serum phosphorus was a significant predictor of progression to ESRD but was replaced by the significant RAC in multivariate models that included the latter. Individuals with significant RAC had a higher risk for reaching the composite outcome. In contrast, there was no association between coronary artery calcification scores and progression to ESRD.
Significant RAC was an independent predictor of progression to ESRD as well as reaching the composite outcome. Understanding the pathogenesis of RAC would allow determination of whether this risk is potentially modifiable.
血管钙化在慢性肾脏病中很常见且严重。由于钙化的后果可能因血管床而异,我们试图验证这样一个假设,即患有蛋白尿和严重肾动脉钙化(RAC)的糖尿病患者进展为终末期肾病的风险更高。
设计、设置、参与者和测量:使用电子束计算机断层扫描,将 RAC 计算为两个肾门和肾动脉的每个部位的 Agatston 评分之和。进行时间事件分析以比较有或无明显 RAC(总评分> 10)的个体的风险。
在研究的 172 名 2 型糖尿病和显性蛋白尿患者中(估计肾小球滤过率 56 ± 25 ml/min/1.73 m 2 ),31%存在明显的 RAC。在 33 ± 21 个月时,41 例进展为终末期肾病,65 例达到复合终点(终末期肾病或死亡)。血清磷是进展为终末期肾病的重要预测指标,但在包括后者的多变量模型中被明显的 RAC 取代。有明显 RAC 的个体发生复合终点的风险更高。相比之下,冠状动脉钙化评分与进展为终末期肾病之间没有关联。
明显的 RAC 是进展为终末期肾病以及达到复合终点的独立预测因素。了解 RAC 的发病机制将有助于确定这种风险是否具有潜在的可变性。